148 related articles for article (PubMed ID: 9011476)
1. Risk factors and prevention of hepatocellular carcinoma in HCV infection.
Benvegnù L; Alberti A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):49S-55S. PubMed ID: 9011476
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype.
Shaltiel T; Zheng S; Siderides C; Gleeson EM; Carr J; Pletcher ER; Cohen NA; Golas BJ; Magge DR; Labow DM; Branch AD; Sarpel U
Cancer; 2021 May; 127(9):1395-1406. PubMed ID: 33629759
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
Hoshida Y; Fuchs BC; Bardeesy N; Baumert TF; Chung RT
J Hepatol; 2014 Nov; 61(1 Suppl):S79-90. PubMed ID: 25443348
[TBL] [Abstract][Full Text] [Related]
4. Viral hepatitis and hepatocellular carcinoma.
Michielsen PP; Francque SM; van Dongen JL
World J Surg Oncol; 2005 May; 3():27. PubMed ID: 15907199
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for hepatocellular carcinoma in India.
Kar P
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S34-42. PubMed ID: 25755609
[TBL] [Abstract][Full Text] [Related]
6. Viral genotypes and associated risk factors of hepatocellular carcinoma in India.
Sarma MP; Asim M; Medhi S; Bharathi T; Diwan R; Kar P
Cancer Biol Med; 2012 Sep; 9(3):172-81. PubMed ID: 23691475
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for hepatocellular carcinoma associated with hepatitis C genotype 3 infection: A systematic review.
Farooq HZ; James M; Abbott J; Oyibo P; Divall P; Choudhry N; Foster GR
World J Gastrointest Oncol; 2024 Apr; 16(4):1596-1612. PubMed ID: 38660636
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma.
Arbuthnot P; Thompson LJ
World J Gastroenterol; 2008 Mar; 14(11):1670-81. PubMed ID: 18350598
[TBL] [Abstract][Full Text] [Related]
9. Serum MicroRNAs as Predictors for HCV Progression and Response to Treatment in Pakistani Patients.
Manzoor S; Malik IR; Jahan S; Sarwar MB; Bashir A; Shams S; Hussain A
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833368
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study].
Cohen D; Shimakawa Y; Ndow G; Sow A; Tamba S; Njie R; Lo G; Ghosh S; Toure-Kane C; Ka M; Mboup S; Okeke E; Toure S; Diop M; D'Alessandro U; Taylor-Robinson S; Mendy M; Zoulim F; Thursz MR; Lemoine M; Chemin I
Med Sci (Paris); 2019 May; 35(5):431-439. PubMed ID: 31115326
[TBL] [Abstract][Full Text] [Related]
11. The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.
Persico M; Bruno S; Costantino A; Mazza M; Almasio PL
Int J Hepatol; 2011; 2011():314301. PubMed ID: 22164334
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.
Fujiwara N; Friedman SL; Goossens N; Hoshida Y
J Hepatol; 2018 Mar; 68(3):526-549. PubMed ID: 28989095
[TBL] [Abstract][Full Text] [Related]
13. Association between hepatitis C and hepatocellular carcinoma.
de Oliveria Andrade LJ; D'Oliveira A; Melo RC; De Souza EC; Costa Silva CA; Paraná R
J Glob Infect Dis; 2009 Jan; 1(1):33-7. PubMed ID: 20300384
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis-C-Related Hepatocellular Carcinoma, Still a Relevant Etiology beyond a Hepatitis C Infection Cure.
Vargas-Accarino E; Higuera M; Buti M; Mínguez B
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672603
[TBL] [Abstract][Full Text] [Related]
15. A review of alcohol-pathogen interactions: New insights into combined disease pathomechanisms.
Osna NA; New-Aaron M; Dagur RS; Thomes P; Simon L; Levitt D; McTernan P; Molina PE; Choi HY; Machida K; Sherman KE; Riva A; Phillips S; Chokshi S; Kharbanda KK; Weinman S; Ganesan M
Alcohol Clin Exp Res; 2022 Mar; 46(3):359-370. PubMed ID: 35076108
[TBL] [Abstract][Full Text] [Related]
16. The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis.
Capasso M; Cossiga V; Guarino M; Ranieri L; Morisco F
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672587
[TBL] [Abstract][Full Text] [Related]
17. Specific MiRNAs in naïve T cells associated with Hepatitis C Virus-induced Hepatocellular Carcinoma.
Yan P; Pang P; Hu X; Wang A; Zhang H; Ma Y; Zhang K; Ye Y; Zhou B; Mao J
J Cancer; 2021; 12(1):1-9. PubMed ID: 33391397
[TBL] [Abstract][Full Text] [Related]
18. Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature.
Engelskircher SA; Chen PC; Strunz B; Oltmanns C; Ristic T; Owusu Sekyere S; Kraft ARM; Cornberg M; Wirth T; Heinrich B; Björkström NK; Wedemeyer H; Woller N
Hepatology; 2024 Feb; ():. PubMed ID: 38381525
[TBL] [Abstract][Full Text] [Related]
19. The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity.
Stauffer W; Bobardt M; Ure D; Foster R; Gallay P
bioRxiv; 2023 Aug; ():. PubMed ID: 37645728
[TBL] [Abstract][Full Text] [Related]
20. Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy.
Miyanishi K; Hoki T; Tanaka S; Kato J
World J Hepatol; 2015 Mar; 7(3):593-9. PubMed ID: 25848483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
